A Wall Street Journal report published Thursday alleged that Theranos, the $10-billion health startup whose blood tests can allegedly be done with a single drop, has a few problems. In a follow-up ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback